McKinsey & Company to pay $650 million for role in opioid crisis
Briefly

U.S. Attorney Christopher Kavanaugh stated, "McKinsey's strategy resulted in prescriptions for Oxycontin that were unsafe and medically unnecessary," emphasizing the grave impact of their actions.
The settlement includes a "deferred prosecution" agreement, meaning McKinsey's executives will evade criminal charges unless further wrongdoing occurs related to opioids.
Read at www.npr.org
[
|
]